D-1591-2014 Class I Terminated
FDA drug recall D-1591-2014 was initiated by Baxter Healthcare Corp. on Jul 11, 2014 and is designated Class I. Reason for recall: Presence of Particulate Matter: particulate matter identified as fibers and/or plastics. The recall status is terminated (terminated Sep 21, 2016). Affected quantity: a) 217,536 bags; b) 161,760 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 24, 2014
- Initiation Date
- Jul 11, 2014
- Termination Date
- Sep 21, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 217,536 bags; b) 161,760 bags
Product Description
0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.
Reason for Recall
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
Distribution Pattern
Nationwide, Puerto Rico, Singapore, and Hong Kong
Code Information
Lot #: a) P309187, Exp 10/14; b) P298190, Exp 08/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1591-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026